Cancer-Related Breakthrough Pain

Front Cover
Oxford University Press, May 27, 2019 - 112 pages
Breakthrough pain is a common occurrence in patients with cancer pain, and is often associated with a deleterious effect on daily life, impairing quality of life substantially. It is a heterogeneous condition, and management needs to be individualized.

This valuable pocketbook discusses the clinical features of breakthrough cancer pain and the different strategies for management. It covers assessment, treatment, and reassessment. It also reviews the evidence for pharmacological interventions, like rapid onset opioids, as well as non-pharmacological interventions and disease modifying treatments.

This new edition has been thoroughly updated to account for recent developments within the field. These updates ensure that Cancer-Related Breakthrough Pain (Oxford Pain Management Library) continues to be an invaluable resource for specialists and trainees in palliative care and pain management, as well as being a quick reference guide for GPs, specialist nurses, and other healthcare professionals.


What people are saying - Write a review

We haven't found any reviews in the usual places.


1 Introduction
2 Clinical features
3 Assessment
4 General principles of management
5 Oral and parenteral opioids
6 Oral transmucosal opioids
7 Intranasal and intrapulmonary opioids
8 Nonopioid analgesics
9 Other therapeutic interventions

Other editions - View all

Common terms and phrases

About the author (2019)

Dr Andrew Davies is a Consultant in Palliative Medicine from the United Kingdom. He has a long-standing clinical / research interest in breakthrough cancer pain (BTcP). He was the chair of the working group that produced the APM recommendations on BTcP, contributed to the EONS guidelines on BTcP, and has written numerous peer reviewed journal articles on the subject. He is current President of the APM, and is President-Elect of the MASCC.

Bibliographic information